BetterLife Pharma Inc. Stock Other OTC
Equities
BETRF
CA08772P2026
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 18.18M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.38M | Net income 2023 | -9M -12.29M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 190K | Net Debt 2023 | 71.69K 97.87K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
1st Jan change | Capi. | |
---|---|---|
-2.62% | 103B | |
+1.79% | 95.28B | |
+1.46% | 22.15B | |
-15.62% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.73% | 16.05B | |
+5.39% | 13.68B | |
+34.40% | 12.17B |